Adagene vs Apollomics
Adagene and Apollomics are similar in size: $7.7m and $8.5m of revenue in their latest fiscal years. Apollomics kept more of each dollar of sales as profit: a net margin of -128.7% against -229.6%.
| Latest fiscal year | AdageneADAG, 2025 | ApollomicsAPLM, 2025 |
|---|---|---|
| Revenue | $7.7m | $8.5m |
| Revenue growth | 7332.8% | — |
| Net income | −$17.6m | −$10.9m |
| Operating margin | -279.5% | — |
| Net margin | -229.6% | -128.7% |
| Return on equity | -41.0% | — |
| Free cash flow | −$15.7m | −$10.4m |
| Cash | $74.5m | $3.3m |
| Total debt | $6.1m | $0 |
| Debt to equity | 17.3% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | — |
| Market value | $113m | $30.1m |
| Price vs our value range | — | — |
| Moat score | — | — |
| Insider trades, 12 months | 5 buys, 0 sales | 5 buys, 0 sales |